CHA Medical and Bio Group said Wednesday that it has begun constructing its Cell Gene Biobank (CGB) facility in Pangyo, Gyeonggi Province.The group has invested 300 billion won ($247.5 million) in the project. The new facility will be on a 710,000 square feet site to become one of the world's most e
The U.S. obesity treatment Semalgultide can reduce up to 13.2 percent of the weight in East Asians, Seoul National University Bundang Hospital said Tuesday based on its phase 3 clinical trial results.The announcement came as the number of obese patients worldwide increased further due to the recent
Recently, a professor at the psychiatry department of a university hospital in Seoul received a warning from the Health Insurance Review and Assessment Service (HIRA) for “attempting a duplicate prescription order of psychotropic drugs.”Two months ago, the patient received a 60-day prescription but
A research team at Bundang CHA Hospital has developed a treatment to inhibit the growth of Poly(rC)-binding protein 1 (PCBP1) gene for treating head and neck cancer resistant to existing anticancer drugs.When inhibiting the PCBP1 gene, a phenomenon called ferroptosis cell death appears. Recent resea
A research team at Yonsei University College of Medicine (YUCM) has revealed the characteristics of liver cancer with a poor prognosis through a study on the subtypes and characteristics of hepatocellular carcinoma and intrahepatic biliary tract cancer.Hepatocellular carcinoma and intrahepatic bilia
A research team at Bundang CHA Hospital has developed a new treatment method that overcomes the resistance of Ibrance, a treatment for metastatic breast cancer, for the first time in the world.Ibrance is a targeted anticancer drug developed by Pfizer and treats hormone receptor (HR)-positive subtype
Catholic University Korea Industry-Academic Cooperation Foundation has licensed out an immune tolerance dendritic cell to treat myocardial infarction and its manufacturing method, developed by Professor Jang Ki-yuk at Seoul St. Mary's Hospital, to Pharos Vaccine.Dendritic cells are a type of special
Myongji Hospital said Friday that it has educated nine medical doctors and researchers from four countries as infectious disease experts by transferring the “K-quarantine” know-how.On Thursday, the hospital held a graduation ceremony for the first nine graduates of the "Lee Jong-wook Fellowship Prog
A Seoul National University Bundang Hospital (SNUBH) team has discovered a protein biomarker that distinguishes molecular types of endometrial cancer.The uterus has two large categories the cervix, the entrance to the uterus, and the uterine body, where the fetus grows. Endometrial cancer arises fro
A research team at Seoul National University Hospital (SNUH) has found that women in their 20s and 30s with a single nucleotide polymorphism (SNP) mutation in a specific gene were more likely to develop female-type females androgenic alopecia, a type of hair loss.Female-type androgenic alopecia is t
A research team at the National Cancer Center (NCC) has found that applying hyperthermic intraperitoneal chemotherapy (HIPEC) after interval cytoreductive surgery can increase the survival rate of ovarian cancer patients.Ovarian cancer has the highest mortality rate among gynecological cancers despi
The Korea Institute of Science and Technology (KIST) said Wednesday that its research team has developed a method to use ultrasonic waves to recharge electronic devices implanted in the human body.According to KIST, the number of patients using implantable electronic devices, such as artificial pace
A Korea Advanced Institute of Science and Technology (KAIST) research team has uncovered the root cause of individual cells' different degrees of response to the same external stimuli, such as antibiotics, using mathematics.Cells in a person’s body have a signal transduction system that responds to
A Korea-U.S. research team has developed a method to predict the response of an immune checkpoint inhibitor in gastric cancer patients.According to Severance Hospital, Jung Jae-ho, a gastrointestinal surgery professor, discovered a gene signature that can predict the immune checkpoint inhibitor resp
As the Omicron infections rapidly push up the number of Covid-19 cases, many suffer from long Covid symptoms.While there are not many hospitals to treat post-Covid-19 conditions, Myongji Hospital on Monday opened “Post Covid-19 Syndrome Clinic” to provide care for those with long Covid symptoms.The
A research team at Kyungpook National University Hospital (KNUH) has discovered that liver cancer cells exposed to sorafenib induce anticancer drug resistance by supplying amino acids through macropinocytosis.The researchers expect that the finding would lead to a new method to increase the effectiv
A research team at Gachon University College of Medicine has discovered a bioactive peptide that activates mTORC1, a major regulator of muscle mass regulation and muscle cell differentiation.The team, led by Professors Yoon Mi-sup and Choi Chul-soo of the Department of Molecular Medicine, also devel
As the cumulative caseload of Covid-19 exceeds 7 million in Korea, Myongji Hospital has opened the “Long Covid Clinic,” which will treat patients cured of Covid-19 but suffer from its aftereffects.The clinic, the first such one responsible for long covid, will treat various aftereffects Covid-19 pat
ALYND (A Leading Yonsei Network for Biopharmaceutical R&D), an R&D consulting center under Yonsei University Health System, said it would conduct a synthetic control arm (SCA) study on adult acute lymphoblastic leukemia, jointly with the National Institute of Food and Drug Safety Evaluation’s toxici
The recent regulatory nod for Viatris’ Dovprela (ingredient: pretomanid) for the treatment of extensively drug-resistant tuberculosis (XDR-TB) will shorten the disease treatment period, an expert said.Viatris Korea held a news conference on Tuesday to mark World TB Day (March 24) to share the nation